关注
Ki Duk Park
Ki Duk Park
在 kist.re.kr 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson’s disease therapy
SY Woo, JH Kim, MK Moon, SH Han, SK Yeon, JW Choi, BK Jang, ...
Journal of medicinal chemistry 57 (4), 1473-1487, 2014
2372014
Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer’s disease via H2O2 production
H Chun, H Im, YJ Kang, Y Kim, JH Shin, W Won, J Lim, Y Ju, YM Park, ...
Nature neuroscience 23 (12), 1555-1566, 2020
1872020
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease
JH Park, YH Ju, JW Choi, HJ Song, BK Jang, J Woo, H Chun, HJ Kim, ...
Science advances 5 (3), eaav0316, 2019
1372019
α-Pinene, a major constituent of pine tree oils, enhances non-rapid eye movement sleep in mice through GABAA-benzodiazepine receptors
H Yang, J Woo, AN Pae, MY Um, NC Cho, KD Park, M Yoon, J Kim, ...
Molecular pharmacology 90 (5), 530-539, 2016
1292016
Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents
KD Park, JH Lee, SH Kim, TH Kang, JS Moon, SU Kim
Bioorganic & medicinal chemistry letters 16 (15), 3913-3916, 2006
1072006
Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives
JM Song, KD Park, KH Lee, YH Byun, JH Park, SH Kim, JH Kim, ...
Antiviral Research 76 (2), 178-185, 2007
982007
Aberrant tonic inhibition of dopaminergic neuronal activity causes motor symptoms in animal models of Parkinson’s disease
JY Heo, MH Nam, HH Yoon, J Kim, YJ Hwang, W Won, DH Woo, JA Lee, ...
Current Biology 30 (2), 276-291. e9, 2020
942020
Useful tools for biomolecule isolation, detection, and identification: acylhydrazone-based cleavable linkers
KD Park, R Liu, H Kohn
Chemistry & biology 16 (7), 763-772, 2009
942009
Activation of astrocytic μ-opioid receptor causes conditioned place preference
MH Nam, KS Han, J Lee, W Won, W Koh, JY Bae, J Woo, J Kim, E Kwong, ...
Cell reports 28 (5), 1154-1166. e5, 2019
932019
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors
JW Choi, BK Jang, N Cho, JH Park, SK Yeon, EJ Ju, YS Lee, G Han, ...
Bioorganic & Medicinal Chemistry 23 (19), 6486-6496, 2015
872015
In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating …
Y Wang, JM Brittain, BW Jarecki, KD Park, SM Wilson, B Wang, R Hale, ...
Journal of Biological Chemistry 285 (33), 25296-25307, 2010
862010
Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model
S Kim, ANI Viswanath, JH Park, HE Lee, AY Park, JW Choi, HJ Kim, ...
Neuropharmacology 167, 107989, 2020
822020
Astrocytes control sensory acuity via tonic inhibition in the thalamus
H Kwak, W Koh, S Kim, K Song, JI Shin, JM Lee, EH Lee, JY Bae, GE Ha, ...
Neuron 108 (4), 691-706. e10, 2020
812020
CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide
A Moutal, X Yang, W Li, KB Gilbraith, S Luo, S Cai, L François-Moutal, ...
Pain 158 (12), 2301-2319, 2017
772017
Synthesis and Anticonvulsant Activities of (R)-N-(4′-Substituted)benzyl 2-Acetamido-3-methoxypropionamides
C Salomé, E Salomé-Grosjean, KD Park, P Morieux, R Swendiman, ...
Journal of medicinal chemistry 53 (3), 1288-1305, 2010
732010
N-Benzylbenzamides: a new class of potent tyrosinase inhibitors
SJ Cho, JS Roh, WS Sun, SH Kim, KD Park
Bioorganic & medicinal chemistry letters 16 (10), 2682-2684, 2006
722006
(S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation …
A Moutal, LA Chew, X Yang, Y Wang, SK Yeon, E Telemi, S Meroueh, ...
Pain 157 (7), 1448-1463, 2016
632016
Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors
KD Park, P Morieux, C Salomé, SW Cotten, O Reamtong, C Eyers, ...
Journal of medicinal chemistry 52 (21), 6897-6911, 2009
632009
(S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5
A Moutal, L François-Moutal, S Perez-Miller, K Cottier, LA Chew, SK Yeon, ...
Molecular neurobiology 53, 1959-1976, 2016
602016
Excessive astrocytic GABA causes cortical hypometabolism and impedes functional recovery after subcortical stroke
MH Nam, J Cho, DH Kwon, JY Park, J Woo, JM Lee, S Lee, HY Ko, ...
Cell reports 32 (1), 2020
562020
系统目前无法执行此操作,请稍后再试。
文章 1–20